Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Attila Fekésházy is active.

Publication


Featured researches published by Attila Fekésházy.


Magyar onkologia | 2009

[The advantage of Positron Emission Tomography combined with Computer Tomography (PET-CT) in the diagnosis of lung cancer (experience with 408 patients)].

Miklós Zsiray; Zsolt Markóczy; Melinda Magyar; Zsolt Lengyel; Attila Fekésházy; Katalin Borbély

The authors analyzed the results of PET-CT scans made with oncological indications among 408 patients. One hundred and fifty-four PET-CTs were done to characterize pulmonary foci, after which in 59 cases lung surgery was performed. The methods sensitivity in respect to malignancy was 100%, specificity was 56%. Staging of affected lymph nodes resulted in 17 mediastinoscopies and 54 thoracotomies. In the former indications PET-CT-positive lymph nodes always need cytologic/histologic verification. M-staging done with PET-CT was performed in 141 cases, mediastinal restaging of patients having received neoadjuvant chemotherapy was done in 24 cases. The latter indications we consider superfluous because of the diagnostic inaccuracy of PET-CT. In 175 cases we analyzed the frequently determining factor of the PET-CT scan in the indication of lung surgery. The authors wish to share their experience for the better use of this method and to accelerate the inclusion of PET-CT into the diagnostic protocol.


Orvosi Hetilap | 2009

[PET/CT based radiotherapy treatment planning in head and neck cancers].

Dániel Sinkó; Tímea Klinkó; Csaba Weisz; Csaba Nemeskéri; Attila Fekésházy; Viktória Tóth; Zoltán Tóth; Árpád Mayer

The purpose of this study was to evaluate the experiences of PET/CT based radiation planning in patients suffering from head and neck cancer. PET/CT based 3D-conformal irradiation was used in eleven patients between March 2008 and February 2009. In six of the eleven cases the therapeutic plan was modified after PET/CT examination, as the previously determined lymph node negative state proved to be lymph node positive. For that reason, the treatment needed to be completed by chemotherapy and in some cases clinical target volume and planning target volume have been also modified. PET/CT examination has a decisive influence on therapeutic planning and on the planning process in patients with head and neck cancer.


Magyar onkologia | 2009

A számítógépes rétegvizsgálattal kombinált pozitronemissziós tomogrÁFIA (PET-CT) diagnosztikus értéke tüdőrákban (Tapasztalataink 408 beteg kapcsán)@@@The advantage of Positron Emission Tomography combined with Computer Tomography (PET-CT) in the diagnosis of lung cancer, our own experience with 408 patients

Miklós Zsiray; Zsolt Markóczy; Melinda Magyar; Zsolt Lengyel; Attila Fekésházy; Katalin Borbély

The authors analyzed the results of PET-CT scans made with oncological indications among 408 patients. One hundred and fifty-four PET-CTs were done to characterize pulmonary foci, after which in 59 cases lung surgery was performed. The methods sensitivity in respect to malignancy was 100%, specificity was 56%. Staging of affected lymph nodes resulted in 17 mediastinoscopies and 54 thoracotomies. In the former indications PET-CT-positive lymph nodes always need cytologic/histologic verification. M-staging done with PET-CT was performed in 141 cases, mediastinal restaging of patients having received neoadjuvant chemotherapy was done in 24 cases. The latter indications we consider superfluous because of the diagnostic inaccuracy of PET-CT. In 175 cases we analyzed the frequently determining factor of the PET-CT scan in the indication of lung surgery. The authors wish to share their experience for the better use of this method and to accelerate the inclusion of PET-CT into the diagnostic protocol.


International Journal of Radiation Oncology Biology Physics | 2004

Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. evidence based on a 12-year follow-up of 70 patients

Zsuzsa Póti; Csaba Nemeskéri; Attila Fekésházy; Géza Sáfrány; Gábor Bajzik; Zoltán P. Nagy; Mária Bidlek; István Sinkovics; Nóra Udvarhelyi; Gabriella Liszkay; Imre Repa; László Galuska; Lajos Trón; Árpád Mayer; Olga Ésik


Orvosi Hetilap | 2002

Költséghatékony onkológiai PET-vizsgálatok.

Beáta Kálvin; Attila Fekésházy; Zsolt Lengyel; Szabolcs Szakáll; Péter Ágoston; Erzsébet Lengyel; Judit Székely; Erika Várady; László Galuska; Lajos Trón; Olga Ésik


Magyar onkologia | 2002

[Cost-effective PET investigations in oncology].

Kálvin B; Attila Fekésházy; Zsolt Lengyel; Szabolcs Szakáll; Péter Ágoston; Lengyel E; Székely J; Galuska L; Lajos Trón; Olga Ésik


Orvosi Hetilap | 2002

Standard PET-vizsgálati protokollok.

Zsolt Lengyel; Attila Fekésházy; Beáta Kálvin; László Galuska; Szabolcs Szakáll


Orvosi Hetilap | 2002

A pozitronemissziós tomográfia alkalmazási lehetóségei a tüdógyógyászati onkológiában.

Attila Fekésházy; Tünde Miklovicz; Olga Ésik; Zsolt Lengyel; Agota Petrányi; András Koncz


Archive | 2013

Characteristics of brown adipose tissue FDG uptake on PET-CT images

Zoltán Tóth; Attila Forgács; József Varga; László Kiss; Laszlo Papp; Attila Fekésházy; Tamás Györke; P. Szabó; Ildikó Garai; Varga József; Fekésházy Attila; Györke Tamás; Garai Ildikó


Society of Nuclear Medicine Annual Meeting Abstracts | 2011

The value of 18F-FDG PET/CT in the management of patients with lung cancer

Miklós Zsiray; Zsolt Markóczy; Zsolt Lengyel; Attila Fekésházy; Miklós Kásler; Katalin Borbély

Collaboration


Dive into the Attila Fekésházy's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lajos Trón

University of Debrecen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge